Júlia Companys-Alemany

6PUBLICATIONS
14CO-AUTHORS
Life historiesSpeciation and extinctionCheminformatics and quantitative structure-activity relationshipsGene expression (incl. microarray and other genome-wide approaches)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2024
Changes in Gene Expression Profile with Age in SAMP8: Identifying Transcripts Involved in Cognitive Decline and Sporadic Alzheimer's Disease.

Christian Griñán-Ferré, Iris Valeria Servin-Muñoz, Verónica Palomera-Ávalos

|Oct 23, 2021
Inhibition of 11β-HSD1 Ameliorates Cognition and Molecular Detrimental Changes after Chronic Mild Stress in SAMP8 Mice.

Dolors Puigoriol-Illamola, Júlia Companys-Alemany, Kris McGuire

|Apr 03, 2021
Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease.

Christian Griñán-Ferré, Júlia Companys-Alemany, Júlia Jarné-Ferrer

|Apr 03, 2020
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice.

Júlia Companys-Alemany, Andreea L Turcu, Aina Bellver-Sanchis

Pageof 1